Hepatitis C is a serious public health issue.
- Nearly 50,000 Philadelphians are estimated to be living with hepatitis C, a chronic virus that can cause cirrhosis, liver cancer and death.
- More than 50% of people living with hepatitis C do not know they are infected.
- Deaths from hepatitis C have surpassed HIV/AIDS death in America due to undiagnosed liver cancer or advanced liver disease related to hepatitis C
Philadelphia is mobilized to respond to hepatitis C
- Approximately 50,000 Philadelphians are living with hep C
- Since February 2012, over 300 people have participated in HepCAP
- HepCAP is a member of the National Viral Hepatitis Roundtable through which we engage with other national leaders to improve hep C policies
HepCAP has helped more people gain access to care & treatment
- Treatment for hep C can now cure most infected people of the virus – when they are able to access the expensive new therapies
- HepCAP is an incubator of ideas; partners generate strategies to improve hepatitis education, prevention, care, treatment, and awareness
HepCAP has built a community of partners dedicated to improving hepatitis services in Philadelphia.
- HepCAP members include people living with hep C, representatives of city agencies, non- profits, hospitals, universities, industry and more.
- HepCAP is made up of more than 50 agencies that can be mobilized to provide services in communities most at-risk for hep C